Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Lakefront Biotherapeutics(LKFT) the Revenue is 13.84 M (-81.89%), Beat estimate;the EBIT is -49.72 M (+25.52%), Beat estimate;the EPS is 0.0343 (+101.8%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.01B81.89%
0.01B90.84%
+0.01B8.95%
EBITExceed expectations
-0.05B25.52%
-0.91B1259.78%
+0.86B1,285.30%
EPSExceed expectations
0.0343101.83%
-13.1399601.59%
+13.1742703.42%
Upcoming earnings report - FY2026 Q3 Earning Release
Available dateNov 12, 2026
Estimate Revenue6.994 M
Estimate EBIT--
Estimate EPS-0.4443
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf